| Primary |
| Angioplasty |
19.0% |
| Percutaneous Coronary Intervention |
19.0% |
| Angina Pectoris |
14.3% |
| Anticoagulant Therapy |
9.5% |
| Antiplatelet Therapy |
9.5% |
| Product Used For Unknown Indication |
9.5% |
| Drug Therapy |
4.8% |
| Drug Use For Unknown Indication |
4.8% |
| Pulmonary Embolism |
4.8% |
| Stent Placement |
4.8% |
|
| Puncture Site Haemorrhage |
21.4% |
| Vascular Pseudoaneurysm |
14.3% |
| Circulatory Collapse |
7.1% |
| Procedural Complication |
7.1% |
| Pulseless Electrical Activity |
7.1% |
| Subdural Haemorrhage |
7.1% |
| Thrombosis |
7.1% |
| Thrombosis In Device |
7.1% |
| Ventricular Fibrillation |
7.1% |
| Vessel Puncture Site Haematoma |
7.1% |
| Wheezing |
7.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
17.7% |
| Product Used For Unknown Indication |
16.0% |
| Thrombosis Prophylaxis |
10.6% |
| Acute Coronary Syndrome |
10.3% |
| Percutaneous Coronary Intervention |
7.9% |
| Pulmonary Embolism |
7.0% |
| Deep Vein Thrombosis |
6.5% |
| Vena Cava Thrombosis |
4.8% |
| Anticoagulant Therapy |
3.8% |
| Renal Vein Thrombosis |
3.2% |
| Antiplatelet Therapy |
2.6% |
| Angina Pectoris |
1.8% |
| Ill-defined Disorder |
1.3% |
| Cerebrovascular Accident |
1.1% |
| Intracardiac Thrombus |
1.1% |
| Peripheral Ischaemia |
1.1% |
| Angioplasty |
0.9% |
| Acute Myocardial Infarction |
0.8% |
| Myocardial Infarction |
0.8% |
| Blood Cholesterol |
0.6% |
|
| Thrombocytopenia |
15.3% |
| Vena Cava Thrombosis |
8.1% |
| Hypertension |
7.2% |
| Multi-organ Failure |
7.2% |
| Subdural Haemorrhage |
6.3% |
| Thrombosis In Device |
6.3% |
| Bradycardia |
5.4% |
| Incorrect Route Of Drug Administration |
4.5% |
| Peripheral Embolism |
4.5% |
| Coma Scale Abnormal |
3.6% |
| Hypotonia |
3.6% |
| Renal Failure |
3.6% |
| Respiratory Distress |
3.6% |
| Retroperitoneal Haemorrhage |
3.6% |
| Vomiting |
3.6% |
| Haemoglobin Decreased |
2.7% |
| Haemorrhage Intracranial |
2.7% |
| Prescribed Overdose |
2.7% |
| Procedural Complication |
2.7% |
| Sick Sinus Syndrome |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
33.1% |
| Product Used For Unknown Indication |
33.1% |
| Percutaneous Coronary Intervention |
6.0% |
| Acute Coronary Syndrome |
4.3% |
| Coagulopathy |
2.8% |
| Acute Myocardial Infarction |
2.5% |
| Deep Vein Thrombosis |
2.4% |
| Anticoagulant Therapy |
1.9% |
| Pain |
1.8% |
| Sedation |
1.6% |
| Coronary Arterial Stent Insertion |
1.5% |
| Pulmonary Embolism |
1.5% |
| Cardiac Failure |
1.3% |
| Angiogram |
1.2% |
| Stent Placement |
1.2% |
| Sedative Therapy |
1.0% |
| Coronary Artery Bypass |
0.9% |
| Chest Pain |
0.7% |
| Cardiac Operation |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
|
| Thrombosis In Device |
9.5% |
| Renal Failure |
7.9% |
| Thrombosis |
7.9% |
| Renal Failure Acute |
6.3% |
| Respiratory Failure |
6.3% |
| Vena Cava Thrombosis |
6.3% |
| Venous Thrombosis |
6.3% |
| Ventricular Tachycardia |
6.3% |
| Cardiogenic Shock |
4.8% |
| Thrombocytopenia |
4.8% |
| Vascular Pseudoaneurysm |
4.8% |
| Brain Death |
3.2% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Leukocytosis |
3.2% |
| Myocardial Infarction |
3.2% |
| Presyncope |
3.2% |
| Pulmonary Oedema |
3.2% |
| Retroperitoneal Haemorrhage |
3.2% |
| Stent Occlusion |
3.2% |
| Tendon Rupture |
3.2% |
|
| Interacting |
| Angina Pectoris |
54.2% |
| Angioplasty |
27.1% |
| Drug Use For Unknown Indication |
10.2% |
| Acute Coronary Syndrome |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
|
| Subdural Haemorrhage |
66.7% |
| Puncture Site Haemorrhage |
22.2% |
| Coagulopathy |
11.1% |
|
